Dose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge Strain

Clinical trial NCT05572450 · COMPLETED

Trial details

NCT number: NCT05572450
Sponsor: Hvivo
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Influenza A H1N1

Start date: 2022-09-07
Primary completion: 2022-12-19
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.